Of patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), 85–90% have ANCA, namely anti-myeloperoxidase (MPO) or PR3 antibodies [7, 8]. Here, PRTN3 is linked to granulomatosis with polyangiitis.